抗新型冠状病毒肺炎候选药物利托那韦首批国家对照品研制
熊婧, 刘毅, 刘朝霞, 李婕, 张才煜, 武香香, 何兰
Development of the first national reference substance of ritonavir as a candidate drug against COVID-19
XIONG Jing, LIU Yi, LIU Zhaoxia, LI Jie, ZHANG Caiyu, WU Xiangxiang, HE Lan
中国药物警戒
.
2022, (2): 137
-141
.
DOI: 10.19803/j.1672-8629.2022.02.06
